Cancer Treatment Seen Drawing Medivation Bids – Businessweek

Medivation Inc. (MDVN) (MDVN), which has already quadrupled in a year, is still tempting acquirers with a prostate cancer treatment that’s poised to make it one of the world’s fastest-growing drug developers. Shares of the San Francisco …

Posted in Uncategorized